Bluejay Diagnostics Inc (BJDX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is showing bearish technical indicators, poor financial performance, no positive news or catalysts, and lacks strong trading signals. Additionally, there is no evidence of institutional or insider confidence.
The technical indicators are bearish. The MACD histogram is negative and contracting, RSI is neutral at 20.585, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels with a pivot at 2.013 and S1 at 1.83, indicating further downside risk.
NULL. There are no recent news, events, or trading trends to suggest a positive outlook for the stock.
and net income (-$1,597,632). There is no recent insider or institutional buying activity.
In Q3 2025, revenue remained at $0 with no growth YoY. Net income improved slightly by 7.81% YoY but remains negative at -$1,597,632. EPS dropped significantly by -86.91% YoY to -4.06, indicating worsening profitability. Gross margin remains at 0%.
No analyst ratings or price target changes available.
